Skip to main content
Premium Trial:

Request an Annual Quote

Genstruct, Pfizer Expand Research Partnership

NEW YORK, Nov. 8 (GenomeWeb News) - Genstruct said today that it has extended a collaboration with Pfizer on various projects designed to uncover underlying mechanisms of action and toxicities of medicines.

 

The companies began collaborating in January 2003.

 

The new arrangement includes research projects using Genstruct's Molecular Epistemics platform with a number of Pfizer units including Worldwide Safety Sciences, the Proteomics Global Center of Excellence, and Clinical Sciences, said Genstruct.

 

Specific terms of the multi-year deal were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more